T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Tuesday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 6.0 %

Shares of NASDAQ:TTOO opened at $0.11 on Tuesday. The firm’s 50 day moving average price is $0.18 and its 200-day moving average price is $0.81. T2 Biosystems has a twelve month low of $0.06 and a twelve month high of $6.80.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.